Oncologic outcomes of intravesical therapy in the management of nonmuscle invasive bladder cancer with variant histology

CONCLUSION: In this series of highly-selected patients with NMIBC and VH, bladder-sparing treatment with intravesical therapy demonstrated acceptable oncologic outcomes for most VHs. This may be an acceptable treatment option for patients without plasmacytoid, sarcomatoid, or micropapillary features who are not suitable cystectomy candidates or who prioritize bladder-sparing treatment.PMID:38135626 | DOI:10.1016/j.urolonc.2023.12.005

Source: Urologic Oncology - December 22, 2023 Category: Urology & Nephrology Authors: Zaeem Lone Tarik Benidir Andrew Wood Rebecca A Campbell Reza Alaghehbandan Jianbo Li Georges-Pascal Haber Mohammed Eltemamy Samuel C Haywood Christopher J Weight Byron H Lee Nima Almassi Source Type: research